Pricing
  1. US-listed companies
  2. AMERICAN INTERNATIONAL HOLDINGS CORP.
  3. Raw

AMERICAN INTERNATIONAL HOLDINGS CORP.【AMIH】

Market cap
$97.5K
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Net loss from continuing operations-------6,136,105-10,225,497-2,863,918
Net income (loss) from discontinued operations-------1,203,785244,586-14,199
Amortization of debt discount-----76,230777,96423
Change in derivative liabilities--------2
Depreciation408,635-----55,280-12,698
Derivatives expenses-------4460,960
Forgiveness of loan-------45,500-
Imputed interest expense---1,799---1,979-
Interest expense147,525--1,7992,97669,916---
Gain(Loss) on disposal--------323,262
(Gain) loss on loans settlement-------1,041,445--
Stock issued for services rendered-----234452,624
Stock issued for in process research and development-------601,852-
Inventory-581,622-----1,327-3,8533,8408,998
Prepaid expenses-----346,654-362,187-3,33313,368
Rent deposits-------26,8933,5994,492
Accounts payable and accrued liabilities-316,473-------27,721
Accrued interest payable----85242,564212,69077,296324,025
Accrued compensation - related parties-----58,48896,000-5,5006,500
Deferred revenue - related parties--------11,745
NET CASH USED IN OPERATING ACTIVITIES OF CONTINUING OPERATIONS701,356-------1,888,506-1,644,747
NET CASH USED IN OPERATING ACTIVITIES OF DISCONTINUED OPERATIONS--------323,256-93,003
NET CASH USED IN OPERATING ACTIVITIES--102,248-16,944-14,546-56,090900,435-2,155,944-2,211,762-1,737,750
Capital expenditures for property and equipment397,557----33,55427,392-69,457
Net cash inflow from disposition of Mangoceuticals, Inc.--------85,753
Net cash inflow from disposition of EPIQ MD, Inc.--------298,377
NET CASH PROVIDED IN INVESTING ACTIVITIES OF CONTINUING OPERATIONS--------314,673
NET CASH PROVIDED BY USED IN INVESTING ACTIVITIES OF DISCONTINUED OPERATIONS-------10,000-
NET CASH USED IN INVESTING ACTIVITIES OF DISCONTINUED OPERATIONS-106,766-----103,554-27,39210,000314,673
Proceeds from borrowings - related parties--17,26914,227100,500165,57111,919141,928-
Repayment of borrowings - related parties----86,928121,03840,000141,9282,000
Proceeds from borrowings--------417,758
(Repayment) of borrowings------15,421427,500-
(Repayment) of note payable--------5,483
Proceeds from sales of stock----43,00035,00046,500100,000-
NET CASH PROVIDED BY FINANCING ACTIVITIES OF CONTINUING OPERATIONS-------3410,275
NET CASH USED IN FINANCING ACTIVITIES OF DISCONTINUED OPERATIONS--------25,164-50
NET CASH PROVIDED BY FINANCING ACTIVITIES-608,607102,34317,26914,22756,572443,033947,1803410,225
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS-----1-1,236,1361-1,012,852
Cash paid for interest137,251----27,3522,674106,677-
Common shares issued for notes conversion-------11
Common shares issued for loan settlement-----105,00086,771111,466-
Discounts on convertible notes--------3,756,000-
Initial debt discount--------400,799
Adoption of ASC 842--------69,439
Settlement of derivative liabilities-------1474,735
Gain on disposition of Mangoceuticals, Inc.--------102,092